Home
About Us
Pharmaceutical Industry
Research & Development
Regulatory Affairs
Quality Assurance
Quality Control
Production Department
Project Management
Environmental, Health & Safety (EHS)
Computer System Validation
Microbiology
Pharma SOPs
QA SOP’s
QC SOP’S
Microbiology SOP’s
Production SOP’s
General SOP’s
Clinical Research
Pharmacovigilance
Medical Coding
Courses
Videos
Job Notifications
Select Page
Blogs
Home
Blogs
Case study of Sandoz Canada (2012): Supply shortages due to non-compliance with GMP.
Dr. Yashashwini Reddy
September 26, 2025
No Comments
Research & Development
case study of Ranbaxy Laboratories (India): Data falsification and GMP violations → $500 million settlement with USFDA.
Dr. Yashashwini Reddy
September 26, 2025
No Comments
Research & Development
case study of HeLa Cells & Informed Consent: Use of Henrietta Lacks’ cells without permission sparked bioethics debates
Dr. Yashashwini Reddy
September 26, 2025
No Comments
Research & Development
case study of Tuskegee Syphilis Study (USA, 1932–1972): Unethical human experimentation leading to stronger clinical research ethics rules.
Dr. Yashashwini Reddy
September 26, 2025
No Comments
Research & Development
Case study of Ranbaxy & Glass Particles Recall (2014): Glass particle contamination in injectables.
Dr. Yashashwini Reddy
September 24, 2025
No Comments
Research & Development
Case study of Tylenol Cyanide Crisis (1982): Tampering case → led to tamper-proof packaging regulations.
Dr. Yashashwini Reddy
September 24, 2025
No Comments
Research & Development
case study of the Heparin Contamination (2008): Over sulfated chondroitin sulfate contamination caused deaths
Dr. Yashashwini Reddy
September 24, 2025
No Comments
Research & Development
Case Study: Valsartan Recall (2018): NDMA contamination due to changes in manufacturing process in China.
Dr. Yashashwini Reddy
September 24, 2025
No Comments
Research & Development
Case Study – Zolgensma (Novartis): World’s most expensive drug → debates on affordability of gene therapy
Dr. Yashashwini Reddy
September 24, 2025
No Comments
Research & Development
Case Study – Gilead’s Remdesivir (COVID-19): Emergency use authorization, pricing and access debates.
Dr. Yashashwini Reddy
September 24, 2025
No Comments
Research & Development
« prev
1
2
3
4
5
…
108
next »
Popular Categories
Clinical data Management
(14)
Clinical Research
(16)
Clinical SAS
(1)
Computer System Validation
(8)
Engineering Department
(32)
Environmental, Health & Safety (EHS)
(7)
General SOP’s
(1)
Medical Coding
(11)
Microbiology
(64)
Microbiology SOP’s
(31)
Pharmacovigilance
(34)
Pharma SOPs
(99)
Production Department
(241)
Production SOP’s
(13)
Project Management
(1)
QA SOP’s
(1)
QC SOP’S
(4)
Quality Assurance
(237)
Quality Control
(282)
Regulatory Affairs
(44)
Research & Development
(62)
Warehouse
(4)
Recent Post
Q14: Analytical Procedure Development
Q13: Continuous Manufacturing
Q12: Lifecycle Management
Q11: Development and Manufacture of Drug Substances
Q10: Pharmaceutical Quality System (PQS)
Hello
Chat now via Whatsapp